Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03168672
Other study ID # CT 1401
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 18, 2017
Est. completion date September 18, 2029

Study information

Verified date February 2024
Source DePuy Orthopaedics
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a Post Market Clinical Follow Up (PMCF) study to monitor the safety and performance of the GLOBAL ICON stemless humeral component. The data gathered will be used to support post market surveillance of the device, and may potentially be used for additional market access purposes.


Description:

This study will be multi-centre and non-comparative. Subjects will be recruited and followed up at similar intervals to reflect the standard clinical practice and intended population for wider use of the device. 157 non-randomised subjects will be recruited from approximately 15 sites. A maximum of 30 subjects may be recruited from one site. More than one implanting surgeon may recruit subjects at each site as a designated sub-Investigator. The primary objective of this PMCF study is to confirm device survivorship of the GLOBAL ICON stemless humeral component at 24 months post-operative. The secondary objectives include the evaluation of clinical performance, radiographic performance and safety outcomes at 3, 12, 24, 60 and 120 months post-operatively. Tertiary endpoints in the study will include a mean change from baseline for the Adjusted Constant-Murley Score, the Oxford Shoulder Score, the EQ-5D-5L dimension score and EQ-VAS scores. Radiographic evidence of aseptic loosening and periprosthetic fracture survivorship of the GLOBAL ICON stemless humeral component will be assessed.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 172
Est. completion date September 18, 2029
Est. primary completion date December 13, 2021
Accepts healthy volunteers No
Gender All
Age group 21 Years to 79 Years
Eligibility Inclusion Criteria: Severely painful and/or severely disabled Non-Inflammatory Degenerative Joint Disease (NIDJD) resulting from osteoarthritis (OA) or post traumatic arthritis Patient is willing and able to complete the required post-operative schedule Patient has provided written Informed Consent to participate Exclusion Criteria: Subjects under the age of 21 or over the age of 80 on the day of consent Subjects who have not reached skeletal maturity, regardless of age Inadequate bone stock in the proximal humerus or glenoid fossa for supporting the GLOBAL ICON stemless humeral components Bone that is too soft or porous to support the implant or that is too hard or brittle to allow for proper bone preparation and fixation, i.e osteoporosis or sclerotic bone, where there could be considerable migration of the prosthesis and/or a chance of fracture of the humerus or glenoid Fractures of the proximal humerus that could compromise the fixation of the GLOBAL ICON stemless humeral components Subjects who have undergone previous treatment on the study shoulder that may compromise fixation of the GLOBAL ICON stemless humeral components Revision of a failed hemi, total or reverse shoulder arthroplasty Active local or systemic infection Absent, irreparable or nonfunctional rotator cuff or other essential muscles Subject is receiving, or is scheduled to receive, treatment that the Investigator considers could affect bone quality, such as chemotherapy or high dose corticosteroids Subjects who, at the point of enrolment, already have a GLOBAL ICON shoulder replacement or are scheduled to receive, a contralateral shoulder replacement device Subjects who are known to be pregnant or breastfeeding Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes Subjects with a known medical condition that the Investigator believes would impact the study outcomes (including, but not limited to osteomyelitis, Paget's disease, neuropathies such as Charcot's disease, metastatic or neoplastic disorders) Known polyethylene and/or metal sensitivity or allergy

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Global ICON
The study device is the GLOBAL ICON stemless humeral component, consisting of the Anchor Plate and Humeral Head.

Locations

Country Name City State
Canada Kingston General Hospital Kingston
Germany Vulpius Klinik Bad Rappenau
Germany Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift Hannover
Germany Sportklinik Ravensburg Ravensburg
Netherlands Treant Hospital Emmen
Netherlands Groene Hart Ziekenhuis Gouda
Netherlands Tergooi Hospital Hilversum
United Kingdom Woodend Hospital Aberdeen
United Kingdom The Royal Bournemouth Hospital Bournemouth
United Kingdom North Bristol NHS Trust Bristol
United Kingdom James Cook University Hospital Middlesbrough
United Kingdom City Hospital Nottingham

Sponsors (1)

Lead Sponsor Collaborator
DePuy Orthopaedics

Countries where clinical trial is conducted

Canada,  Germany,  Netherlands,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Adjusted Constant-Murley Score Mean change from baseline for the specified follow up time points 3, 12, 24, 60 and 120 months post-operative
Other Oxford Shoulder Score Mean change from baseline for the specified time points. 3, 12, 24, 60 and 120 months post-operative
Other EQ-5D-5L dimension score Mean change from baseline for the specified time points 3, 12, 24, 60 and 120 months post-operative
Other Radiographic evidence of aseptic loosening Radiographic evidence of aseptic loosening of the GLOBAL ICON stemless humeral component that does not arise as a result of intraoperative error, from a traumatic event or inappropriate subject behaviour immediate post-operative, 3, 12, 24, 60 and 120 months
Other Periprosthetic fracture survivorship Periprosthetic fracture survivorship of the GLOBAL ICON stemless humeral component where a subject is deemed to be surviving following no radiographic evidence of periprosthetic fracture arising as a result of intraoperative error, traumatic event or inappropriate subject behaviour 24, 60 and 120 months post operative
Other EQ-VAS score (subscore of EQ-5D-5L) Mean change from baseline for the specified time points 3, 12, 24, 60 and 120 months post-operative
Primary Composite success, comprised of radiographs, Constant-Murley, no revisions or serious adverse events. The primary endpoint in this study is a composite success endpoint at 24 months post-operative, where an individual study subject is deemed to be a composite success if each of the following criteria is met at the 24 month follow-up visit:
Radiographs indicate that there is no continuous radiolucent line around the GLOBAL ICON stemless humeral component The Adjusted Constant-Murley score is greater than 85 No GLOBAL ICON humeral component has been removed for any reason There have been no device related serious adverse events
24 months
Secondary Adjusted Constant-Murley Score baseline and 3, 12, 24, 60 and 120 months post-operative
Secondary Oxford Shoulder Score baseline and 3, 12, 24, 60 and 120 months post-operative
Secondary EQ-VAS (subscore of EQ-5D-5L) baseline and 3, 12, 24, 60, and 120 months post-operative
Secondary Radiographic evidence of aseptic loosening of the GLOBAL ICON stemless humeral component immediate post-operative and 3, 12, 24, 60 and 120 months post-operative
Secondary GLOBAL ICON stemless humeral component survivorship Overall survivorship of the GLOBAL ICON stemless humeral component where a subject is deemed to be surviving if no components have been removed for any reason. 24, 60 and 120 months post-operative
Secondary EQ-5D-5L Scores by dimension baseline and 3, 12, 24, 60, and 120 months post-operative
See also
  Status Clinical Trial Phase
Completed NCT04657926 - A Trial of APPA in the Treatment of Knee Osteoarthritis Phase 2
Completed NCT02536833 - A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects Phase 2
Completed NCT03014037 - Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration N/A
Recruiting NCT05937542 - A Qualitative Investigation of CLEAT Participants
Completed NCT03644615 - A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis N/A
Recruiting NCT06061367 - Muscles Strength and Gait Parameteres After TKA
Withdrawn NCT04976972 - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT03850665 - Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach N/A
Completed NCT02826902 - Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial N/A
Completed NCT04402502 - Dynamic 4DCT to Examine Wrist Carpal Mechanics N/A
Completed NCT02923700 - Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial Phase 4
Completed NCT04564053 - Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants Phase 1
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Not yet recruiting NCT05036174 - Diphenhydramine Ointment for Knee Osteoarthritis N/A
Recruiting NCT02666443 - Low Dose Dexamethasone in Supraclavicular Blocks N/A
Recruiting NCT02912429 - Onlay vs. Inlay Patellofemoral Arthroplasty N/A
Active, not recruiting NCT02723929 - Effects of tDCS and tUS on Pain Perception in OA of the Knee
Withdrawn NCT02921594 - Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties N/A
Terminated NCT02820766 - Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting N/A